Rights and permissions
About this article
Cite this article
CD40 levels predict benefit from abciximab in ACS. Inpharma Wkly. 1380, 12 (2003). https://doi.org/10.2165/00128413-200313800-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313800-00023